"The Once A Day Protease Inhibitor Regimens"
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00242216|
Recruitment Status : Completed
First Posted : October 19, 2005
Results First Posted : October 17, 2013
Last Update Posted : January 15, 2014
The University of Texas Health Science Center, Houston
Information provided by (Responsible Party):
Roberto Arduino, The University of Texas Health Science Center, Houston
|Study Design||Allocation: Randomized; Intervention Model: Parallel Assignment; Masking: None (Open Label); Primary Purpose: Treatment|
Drug: ritonavir-boosted atazanavir
Drug: ritonavir-boosted fosamprenavir
|Recruitment Details||Patients enrolled at a county clinic|
High porportion of subject did not complete the study.